LLY

1,008.68

-0.23%↓

JNJ

230.1

+0.62%↑

ABBV

212.81

-0.87%↓

UNH

382.38

-2.45%↓

AZN

187.97

+1.45%↑

LLY

1,008.68

-0.23%↓

JNJ

230.1

+0.62%↑

ABBV

212.81

-0.87%↓

UNH

382.38

-2.45%↓

AZN

187.97

+1.45%↑

LLY

1,008.68

-0.23%↓

JNJ

230.1

+0.62%↑

ABBV

212.81

-0.87%↓

UNH

382.38

-2.45%↓

AZN

187.97

+1.45%↑

LLY

1,008.68

-0.23%↓

JNJ

230.1

+0.62%↑

ABBV

212.81

-0.87%↓

UNH

382.38

-2.45%↓

AZN

187.97

+1.45%↑

LLY

1,008.68

-0.23%↓

JNJ

230.1

+0.62%↑

ABBV

212.81

-0.87%↓

UNH

382.38

-2.45%↓

AZN

187.97

+1.45%↑

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Отворен

3.15

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

3.2

Ключови измерители
By Trading Economics
Приходи	-1.5M -4.5M
Марж на печалбата	-2,954
Служители	21

Дивиденти
By Dow Jones
Следващи печалби	6.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	24M
Предишно отваряне	3.15
Предишно затваряне	3.15

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.05.2026 г., 20:36 ч. UTC

Придобивния, сливания и поглъщания

Analog Devices to Buy Empower Semiconductor for $1.5 Billion

19.05.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Decline as Concerns About Energy, Material Costs Persists -- Market Talk

19.05.2026 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Higher on Possible Technical Recovery -- Market Talk

19.05.2026 г., 23:28 ч. UTC

Пазарно говорене

Печалби

Global Forex and Fixed Income Roundup: Market Talk

19.05.2026 г., 23:28 ч. UTC

Пазарно говорене

Печалби

F&P Healthcare's Outlook Key for Investors -- Market Talk

19.05.2026 г., 23:10 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

19.05.2026 г., 23:10 ч. UTC

Пазарно говорене

Kiwi Property's Dividend Growth Reliant on Several Factors -- Market Talk

19.05.2026 г., 22:02 ч. UTC

Печалби

ZTO Express (Cayman): Di Xu to Resign From Board

19.05.2026 г., 22:01 ч. UTC

Печалби

ZTO Express (Cayman) 1Q Adj EPS 43c >ZTO

19.05.2026 г., 22:01 ч. UTC

Печалби

ZTO Express (Cayman) 1Q EPS 39c >ZTO

19.05.2026 г., 22:00 ч. UTC

Печалби

ZTO Express (Cayman) 1Q Rev $1.93B >ZTO

19.05.2026 г., 21:37 ч. UTC

Печалби

Cracks Are Starting to Appear in the Chip Stock Rally -- Barrons.com

19.05.2026 г., 21:31 ч. UTC

Придобивния, сливания и поглъщания

How NextEra Can Fix Dominion's Strange AI Problem -- Barrons.com

19.05.2026 г., 21:01 ч. UTC

Печалби

Home Depot Beats Earnings Estimates as Shoppers Defy Inflation Fears. The Stock Advances. -- Barrons.com

19.05.2026 г., 20:58 ч. UTC

Печалби

These Stocks Are Today's Movers: CoreWeave, Nvidia, Home Depot, Akamai, Agilysys, Micron, and More -- Barrons.com

19.05.2026 г., 20:46 ч. UTC

Горещи акции

Stocks to Watch Recap: ServiceNow, Home Depot, CoreWeave -- WSJ

19.05.2026 г., 20:43 ч. UTC

Пазарно говорене

Canada 30-Year Yield Hits Highest Level Since 2010 -- Market Talk

19.05.2026 г., 20:34 ч. UTC

Печалби

James Hardie Industries Sees FY27 Sales $5.25B-$5.41B >JHX

19.05.2026 г., 20:32 ч. UTC

Печалби

James Hardie Industries: Targeting Pro Forma Adjusted EBITDA Growth of 4% to 8% in FY27 >JHX

19.05.2026 г., 20:32 ч. UTC

Печалби

James Hardie Industries 4Q EPS 5c >JHX

19.05.2026 г., 20:32 ч. UTC

Печалби

James Hardie Industries 4Q Sales $1.4B >JHX

19.05.2026 г., 20:21 ч. UTC

Придобивния, сливания и поглъщания

Analog Devices to Buy Empower Semiconductor for $1.5B

19.05.2026 г., 20:18 ч. UTC

Пазарно говорене

Canada CPI Data Has Accounting Quirk Related to Travel Tours -- Market Talk

19.05.2026 г., 20:13 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

19.05.2026 г., 20:13 ч. UTC

Пазарно говорене

'Hard to Square' Canada Rate Hikes Expectations Given Mild Core -- Market Talk

19.05.2026 г., 20:03 ч. UTC

Придобивния, сливания и поглъщания

Analog Devices: Deal Further Advances Position as Strategic, System-Level Grid-To-Core Power Partner for Hyperscalers, AI Silicon Developers >ADI

19.05.2026 г., 20:03 ч. UTC

Придобивния, сливания и поглъщания

Analog Devices: Phillips Will Continue Leading IVR Technology Efforts as Part of ADI >ADI

19.05.2026 г., 20:02 ч. UTC

Придобивния, сливания и поглъщания

Analog Devices Will Acquire Empower in All-Cash Transaction for $1.5 B >ADI

19.05.2026 г., 20:02 ч. UTC

Придобивния, сливания и поглъщания

Analog Devices to Acquire Empower Semiconductor, Expanding Its Next-Generation High-Density Power Portfolio for the AI Era

19.05.2026 г., 19:23 ч. UTC

Пазарно говорене

Oil Futures Slip With Market Back on U.S.-Iran Deal Watch -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Печалба преди облагане с данъци

Продажби

Оперативна печалба

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.